Core responsibilities
Scientific exchange with HCPs and experts:

• Engage in peer‑to‑peer, compliant scientific discussions with KOLs and HCPs (e.g., allergists, ENT, pulmonologists, pediatricians, GPs) on disease state, clinical evidence, guidelines, and appropriate use of ALK therapies.
• Deliver non‑promotional scientific presentations (1:1 and group) at meetings, clinical sessions, and educational events.
• Support scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care.
• Systematically capture, synthesize, and share field insights (HCPs, reimbursement stakeholders, hospital committees)
• Use approved materials; document field interactions and insights in approved systems (Veeva).
• Monitor and communicate scientific developments, competitor clinical evidence, and guideline updates relevant to ALK’s therapeutic areas.

Market access stakeholder engagement (non‑promotional):

• Map and cultivate scientific relationships with reimbursement and access stakeholders, including INAMI/RIZIV, mutualities/sickness funds, and hospital formulary/P&T committees; engage competent authorities (e.g., AFMPS) for scientific exchange as appropriate, in line with Medical governance and local codes.
• Communicate unbiased, evidence‑based clinical value messages derived from the Global/Local Value Dossier, tailored to the needs of payer and access stakeholders.
• Respond to scientific queries from reimbursement stakeholders and coordinate timely, compliant follow‑up with internal Medical and Market Access colleagues.

Value dossier and scientific support:

• Contribute to the local adaptation of the Global Value Dossier for Belgium: ensure the clinical narrative, comparators, endpoints, epidemiology, and care pathways reflect local practice and expectations.
• Curate, review, and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance.
• Support development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials.

Education: Advanced degree in life sciences (PhD, MD, PharmD, MSc) required.

Experience: Prior MSL/Medical Affairs experience in pharma/biotech strongly preferred; experience engaging with reimbursement stakeholders in Belgium is a plus.

Scientific/clinical: Strong ability to interpret and communicate clinical evidence; familiarity with immunology/allergy/respiratory is advantageous.

Communication: Excellent scientific communication and presentation skills; ability to translate complex clinical evidence into clear, balanced, stakeholder‑appropriate scientific messages.

Project management: Proven ability to manage cross‑functional projects with multiple stakeholders and timelines.

Languages: Fluency in French and English required; proficiency in Dutch preferred (role is Wallonia‑focused but national stakeholder interactions often require Dutch/English).

Other: Valid driver’s license; willingness to travel 60–70% within Wallonia and to Brussels for national engagements.

Location: Belgium (field-based, Wallonia; regular travel to Brussels for national stakeholders)